Emerging nanopharmaceuticals and nanonutraceuticals in cancer management

L Salama, ER Pastor, T Stone, SA Mousa - Biomedicines, 2020 - mdpi.com
Nanotechnology is the science of nanoscale, which is the scale of nanometers or one
billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials …

Ultrasound-responsive materials for drug/gene delivery

X Cai, Y Jiang, M Lin, J Zhang, H Guo, F Yang… - Frontiers in …, 2020 - frontiersin.org
Ultrasound is one of the most commonly used methods in the diagnosis and therapy of
diseases due to its safety, deep penetration into tissue, and non-invasive nature. In the …

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

JB Wang, X Huang, FR Li - Cancer communications, 2019 - Springer
Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the
key factors providing protective immunity against lung tumors and clinical trials have proven …

Stimuli-responsive drug delivery systems for the diagnosis and therapy of lung cancer

X Lin, J Wu, Y Liu, N Lin, J Hu, B Zhang - Molecules, 2022 - mdpi.com
Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death
worldwide. Numerous drugs have been developed to treat lung cancer patients in recent …

Enhanced cellular uptake and gene silencing activity of survivin-siRNA via ultrasound-mediated nanobubbles in lung cancer cells

H Akbaba, G Erel-Akbaba, M Kotmakçı… - Pharmaceutical …, 2020 - Springer
Purpose Paclitaxel is a first-line drug for the therapy of lung cancer, however, drug
resistance is a serious limiting factor, related to overexpression of anti-apoptotic proteins like …

Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells

F Gao, M Li, X Yu, W Liu, L Zhou… - Journal of Cellular and …, 2021 - Wiley Online Library
Dysfunction of epidermal growth factor receptor (EGFR) signalling plays a critical role in the
oncogenesis of non–small‐cell lung cancer (NSCLC). Here, we reported the natural product …

Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies

S Shojaei, M Pourmadadi, M Homayoonfal… - Journal of Drug Delivery …, 2024 - Elsevier
Lung cancer, the second leading cause of cancer-related mortality and incidence globally,
presents a formidable challenge with an estimated 238,340 new cases and 127,070 deaths …

Octaarginine functionalized nanoencapsulated system: In vitro and in vivo evaluation of bFGF loaded formulation for wound healing

G Erel-Akbaba, H Akbaba, E Keselik… - Journal of Drug Delivery …, 2022 - Elsevier
Despite all treatment efforts, diabetic wounds are still a major health concern that needs to
be solved. Growth factor-based therapeutic approaches offer promising results for wound …

Preparation optimization of bovine serum albumin nanoparticles and its application for siRNA delivery

Y Wang, S Chen, X Yang, S Zhang… - … Design, Development and …, 2021 - Taylor & Francis
Background siRNA brings hope for cancer therapy. However, there are many obstacles for
application of siRNA in clinical. Because of the excellent biocompatibility, non-toxicity and …

Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors

C Li, S Liu, B Dong, C Li, L Jian, J He… - Journal of Medicinal …, 2022 - ACS Publications
Tuberculosis is caused by the bacterium Mycobacterium tuberculosis (Mtb) and is ranked as
the second killer infectious disease after COVID-19. Proteasome accessory factor A (PafA) is …